Response to: “A somatization comorbidity phenotype impacts response to therapy in rheumatoid arthritis: post hoc results from the certolizumab pegol phase 4 PREDICT trial”

Overview of attention for article published in Arthritis Research & Therapy, February 2019

Altmetric Badge

Mentioned by

twitter: 1 X user

Readers on

mendeley: 12 Mendeley

So far, Altmetric has seen 1 X post from an account with 1,188 followers.

Response to: “A somatization comorbidity phenotype impacts response to therapy in rheumatoid arthritis: post hoc results from the certolizumab pegol phase 4 PREDICT trial” https://t.co/dV1daLJtBQ

21 Feb 2019

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.